CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade GoodRx Holdings, Inc. - GDRX CFD

5.60
2.1%
Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.08
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 5.72
Open* 5.68
1-Year Change* -0.18%
Day's Range* 5.58 - 5.75
52 wk Range 3.82-9.37
Average Volume (10 days) 1.40M
Average Volume (3 months) 41.71M
Market Cap 2.45B
P/E Ratio 219.61
Shares Outstanding 397.85M
Revenue 745.09M
EPS 0.03
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Nov 6, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 20, 2023 5.72 -0.08 -1.38% 5.80 5.93 5.72
Sep 19, 2023 5.75 0.08 1.41% 5.67 5.77 5.64
Sep 18, 2023 5.73 -0.15 -2.55% 5.88 5.93 5.73
Sep 15, 2023 5.95 -0.20 -3.25% 6.15 6.23 5.86
Sep 14, 2023 6.23 -0.06 -0.95% 6.29 6.50 6.16
Sep 13, 2023 6.29 0.31 5.18% 5.98 6.33 5.95
Sep 12, 2023 6.01 -0.05 -0.83% 6.06 6.27 5.98
Sep 11, 2023 6.16 0.00 0.00% 6.16 6.29 6.09
Sep 8, 2023 6.14 0.15 2.50% 5.99 6.16 5.99
Sep 7, 2023 6.13 -0.04 -0.65% 6.17 6.24 6.02
Sep 6, 2023 6.33 0.03 0.48% 6.30 6.41 6.26
Sep 5, 2023 6.32 -0.10 -1.56% 6.42 6.43 6.27
Sep 1, 2023 6.51 0.04 0.62% 6.47 6.68 6.45
Aug 31, 2023 6.51 -0.05 -0.76% 6.56 6.88 6.50
Aug 30, 2023 6.53 0.30 4.82% 6.23 6.68 6.23
Aug 29, 2023 6.24 0.18 2.97% 6.06 6.46 6.04
Aug 28, 2023 6.11 0.09 1.50% 6.02 6.26 6.02
Aug 25, 2023 6.01 0.07 1.18% 5.94 6.22 5.89
Aug 24, 2023 5.95 -0.11 -1.82% 6.06 6.17 5.94
Aug 23, 2023 6.14 -0.16 -2.54% 6.30 6.36 6.10

GoodRx Holdings, Inc. Events

Time (UTC) Country Event
Monday, November 6, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Goodrx Holdings Inc Earnings Release
Q3 2023 Goodrx Holdings Inc Earnings Release

Forecast

-

Previous

-
Monday, February 26, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Goodrx Holdings Inc Earnings Release
Q4 2023 Goodrx Holdings Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 766.554 745.424 550.7 388.224 249.522
Revenue 766.554 745.424 550.7 388.224 249.522
Cost of Revenue, Total 65.079 46.716 29.587 14.016 6.035
Gross Profit 701.475 698.708 521.113 374.208 243.487
Total Operating Expense 764.816 732.018 826.419 253.425 175.128
Selling/General/Admin. Expenses, Total 487.341 524.903 715.586 191.659 112.536
Research & Development 143.137 125.86 61.816 29.3 43.894
Depreciation / Amortization 54.177 34.539 18.43 13.573 9.806
Operating Income 1.738 13.406 -275.719 134.799 74.394
Interest Income (Expense), Net Non-Operating -24.969 -23.583 -27.753 -48.854 -22.039
Other, Net 0 0 0.022 -2.967 -0.007
Net Income Before Taxes -23.231 -10.177 -303.45 82.978 52.348
Net Income After Taxes -32.828 -25.254 -293.623 66.048 43.793
Net Income Before Extra. Items -32.828 -25.254 -293.623 66.048 43.793
Net Income -32.828 -25.254 -293.623 66.048 43.793
Income Available to Common Excl. Extra. Items -32.828 -25.254 -293.623 66.048 43.793
Income Available to Common Incl. Extra. Items -32.828 -25.254 -293.623 66.048 43.793
Diluted Net Income -32.828 -25.254 -293.623 66.048 43.793
Diluted Weighted Average Shares 412.858 409.981 274.696 383.223 383.223
Diluted EPS Excluding Extraordinary Items -0.07951 -0.0616 -1.0689 0.17235 0.11428
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.04353 -0.03893 -1.06654 0.18248 0.12051
Unusual Expense (Income) 15.082 0 1 4.877 2.857
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 189.677 183.986 184.109 187.318 191.798
Revenue 189.677 183.986 184.109 187.318 191.798
Cost of Revenue, Total 16.339 16.695 17.36 17.395 18.044
Gross Profit 173.338 167.291 166.749 169.923 173.754
Total Operating Expense 171.369 174.491 182.372 203.031 195.845
Selling/General/Admin. Expenses, Total 107.648 108.141 121.257 117.107 126.077
Research & Development 31.285 32.908 36.77 35.921 35.404
Depreciation / Amortization 16.097 14.939 15.533 13.952 13.319
Operating Income 18.308 9.495 1.737 -15.713 -4.047
Interest Income (Expense), Net Non-Operating -6.24 -5.899 -6.482 -6.558 -6.112
Net Income Before Taxes 12.068 3.596 -4.745 -22.271 -10.159
Net Income After Taxes 58.786 -3.29 -1.972 -41.734 -1.415
Net Income Before Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
Net Income 58.786 -3.29 -1.972 -41.734 -1.415
Income Available to Common Excl. Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
Income Available to Common Incl. Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
Diluted Net Income 58.786 -3.29 -1.972 -41.734 -1.415
Diluted Weighted Average Shares 414.335 412.429 411.67 412.956 412.135
Diluted EPS Excluding Extraordinary Items 0.14188 -0.00798 -0.00479 -0.10106 -0.00343
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.14248 -0.00346 -0.02028 -0.06244 0.00579
Other, Net
Unusual Expense (Income) 0 1.808 -8.548 18.656 3.001
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 919.686 1088.83 1086.37 86.582 73.071
Cash and Short Term Investments 757.165 941.109 968.691 26.05 34.6
Cash 757.165 941.109 968.691 26.05 34.6
Total Receivables, Net 121.665 126.411 97.293 48.129 35.023
Accounts Receivable - Trade, Net 117.141 118.08 68.729 48.129 33.359
Prepaid Expenses 40.856 21.307 17.484 12.403 3.448
Total Assets 1604.63 1607.62 1470.11 386.796 314.791
Property/Plant/Equipment, Total - Net 55.726 49.317 50.769 34.175 0.988
Property/Plant/Equipment, Total - Gross 65.495 55.146 52.899 35.442 1.542
Accumulated Depreciation, Total -9.769 -5.829 -2.13 -1.267 -0.554
Goodwill, Net 412.117 329.696 261.116 236.225 220.42
Intangibles, Net 189.937 133.778 56.719 26.445 18.27
Other Long Term Assets, Total 27.165 6.007 15.142 3.369 2.042
Total Current Liabilities 76.32 81.113 59.551 33.373 16.62
Accounts Payable 17.7 17.501 10.291 7.851 7.2
Accrued Expenses 43.712 49.714 35.379 13.691 3.732
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.029 7.029 7.029 7.029 5.43
Other Current Liabilities, Total 7.879 6.869 6.852 4.802 0.258
Total Liabilities 789.804 775.945 758.755 737.369 740.209
Total Long Term Debt 651.796 655.858 659.888 663.893 716.806
Long Term Debt 651.796 655.858 659.888 663.893 716.806
Deferred Income Tax 0.244 3.456
Other Liabilities, Total 61.688 38.73 39.316 40.103 3.327
Total Equity 814.827 831.68 711.359 -350.573 -425.418
Redeemable Preferred Stock 0 0 737.009 737.009
Common Stock 0.04 0.04 0.039 0.46 0.451
Retained Earnings (Accumulated Deficit) -1448.54 -1415.71 -1390.45 -1096.83 -1162.88
Total Liabilities & Shareholders’ Equity 1604.63 1607.62 1470.11 386.796 314.791
Total Common Shares Outstanding 397.025 398.681 391.66 383.223 383.223
Additional Paid-In Capital 2263.32 2247.35 2101.77 8.788
Other Current Assets, Total 0 2.9
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 907.016 919.686 878.388 893.957 994.723
Cash and Short Term Investments 761.075 757.165 728.786 730.54 845.427
Cash 761.075 757.165 728.786 730.54 845.427
Total Receivables, Net 116.442 121.665 124.25 143.194 129.107
Accounts Receivable - Trade, Net 116.442 117.141 120.886 122.878 123.281
Prepaid Expenses 29.499 40.856 25.352 20.223 20.189
Other Current Assets, Total
Total Assets 1611.5 1604.63 1567.06 1592 1538.33
Property/Plant/Equipment, Total - Net 53.683 55.726 50.258 51.384 49.542
Goodwill, Net 412.117 412.117 415.256 415.256 334.642
Intangibles, Net 197.303 189.937 197.199 193.419 138.495
Other Long Term Assets, Total 41.381 27.165 25.958 37.98 20.926
Total Current Liabilities 68.981 76.32 84.966 79.618 59.364
Accounts Payable 12.389 17.7 10.855 16.825 12.82
Accrued Expenses 35.062 43.712 56.084 44.221 29.196
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.029 7.029 7.029 7.029 7.029
Other Current Liabilities, Total 14.501 7.879 10.998 11.543 10.319
Total Liabilities 784.032 789.804 778.656 774.056 751.821
Total Long Term Debt 650.776 651.796 652.814 653.83 654.845
Long Term Debt 650.776 651.796 652.814 653.83 654.845
Other Liabilities, Total 64.275 61.688 40.226 40.153 37.215
Total Equity 827.468 814.827 788.403 817.94 786.507
Common Stock 0.04 0.04 0.04 0.04 0.04
Additional Paid-In Capital 2279.25 2263.32 2234.93 2222.73 2189.88
Retained Earnings (Accumulated Deficit) -1451.82 -1448.54 -1446.56 -1404.83 -1403.41
Total Liabilities & Shareholders’ Equity 1611.5 1604.63 1567.06 1592 1538.33
Total Common Shares Outstanding 396.649 397.025 396.065 397.908 396.132
Redeemable Preferred Stock 0 0 0
Deferred Income Tax 0.65 0.455 0.397
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -32.828 -25.254 -293.623 66.048 43.793
Cash From Operating Activities 146.78 178.779 131.341 83.286 45.253
Cash From Operating Activities 54.177 34.539 18.43 13.573 9.806
Deferred Taxes -0.497 12.851 -10.91 -5.674 -2.433
Non-Cash Items 146.218 168.439 449.903 14.155 5.858
Cash Taxes Paid -4.356 18.105 29.228 19.4 11.7
Cash Interest Paid 30.702 20.198 24.517 48.443 18.658
Changes in Working Capital -20.29 -11.796 -32.459 -4.816 -11.771
Cash From Investing Activities -210.498 -178.733 -91.617 -37.055 -3.458
Capital Expenditures -55.214 -34.457 -35.824 -5.749 -3.458
Other Investing Cash Flow Items, Total -155.284 -144.276 -55.793 -31.306 0
Cash From Financing Activities -120.226 -30.528 905.817 -54.781 -24.734
Financing Cash Flow Items -20.635 -58.52 15.043 -2.214 -1371.97
Issuance (Retirement) of Stock, Net -92.562 35.021 897.803 4.665 740.358
Issuance (Retirement) of Debt, Net -7.029 -7.029 -7.029 -57.232 606.876
Net Change in Cash -183.944 -30.482 945.541 -8.55 17.061
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -3.29 -32.828 -30.856 10.878 12.293
Cash From Operating Activities 32.288 146.78 114.901 81.169 30.12
Cash From Operating Activities 14.939 54.177 38.644 24.692 11.373
Deferred Taxes 0.035 -0.497 -0.141 -0.336 -0.394
Non-Cash Items 29.198 146.218 112.553 65.241 31.732
Changes in Working Capital -8.594 -20.29 -5.299 -19.306 -24.884
Cash From Investing Activities -14.288 -210.498 -211.784 -198.009 -34.401
Capital Expenditures -14.288 -55.214 -39.924 -26.149 -12.418
Cash From Financing Activities -14.09 -120.226 -115.44 -93.729 -91.401
Financing Cash Flow Items -3.523 -20.635 -17.557 -14.288 -9.561
Issuance (Retirement) of Stock, Net -8.809 -92.562 -92.611 -75.926 -80.082
Issuance (Retirement) of Debt, Net -1.758 -7.029 -5.272 -3.515 -1.758
Net Change in Cash 3.91 -183.944 -212.323 -210.569 -95.682
Other Investing Cash Flow Items, Total 0 -155.284 -171.86 -171.86 -21.983

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GoodRx Holdings, Inc. Company profile

GoodRx is a startup company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States. The website gets about fourteen million visitors a month. As of February 25, 2020, "millions of people" had downloaded the GoodRx app.
Industry: Online Services (NEC)

2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US

Income Statement

  • Annual
  • Quarterly

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

US100

14,682.60 Price
-1.850% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

26,639.10 Price
-1.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

XRP/USD

0.51 Price
-1.860% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

ETH/USD

1,590.52 Price
-2.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading